⌘K

Login Start Free

Home/Filings/4/0001415889-25-016225

4//SEC Filing

Jain Rita 4

Accession 0001415889-25-016225

CIK 0000744218other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:10 PM ET

Size

5.7 KB

Accession

0001415889-25-016225

Insider Transaction Report

Form 4

Period: 2025-06-05

Celldex Therapeutics, Inc.CLDX

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2025-06-05+16,500→ 16,500 total
Exercise: $19.53From: 2026-06-05Exp: 2035-06-05→ Common Stock (16,500 underlying)

Footnotes (1)

[F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.

Documents

1 file

4
form4-06092025_080641.xmlPrimary

Issuer

Celldex Therapeutics, Inc.

CIK 0000744218

Entity typeother

Related Parties

1

filerCIK 0001707797

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 4:10 PM ET
Size: 5.7 KB

View on SEC.gov